location_id,location,disease,time,age_group_id,age_group,age,is_filled,gender_id,gender,measure_id,measure,mean,lower,upper
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,False,1,Male,5,Prevalence,6.671651288060804E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,1,Male,5,Prevalence,1.129355500871447E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,1,Male,5,Prevalence,1.9750521032967957E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,1,Male,5,Prevalence,3.406766866019396E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,False,1,Male,6,Incidence,6.671651288060804E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,1,Male,6,Incidence,7.46946943252228E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,1,Male,6,Incidence,1.3312746283640264E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,1,Male,6,Incidence,2.288180346774165E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,True,1,Male,15,mortality,0.4245177531456459,0.5241881829282174,0.5241881829282174
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,1,Male,15,mortality,0.4268157288108092,0.5124610986115096,0.5124610986115096
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,1,Male,15,mortality,0.42996029510681777,0.5017777823172169,0.5017777823172169
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,1,Male,15,mortality,0.43364201790052,0.4921129467327706,0.4921129467327706
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,False,2,Female,5,Prevalence,5.287525431071027E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,2,Female,5,Prevalence,8.946443422020769E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,2,Female,5,Prevalence,1.563750687727533E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,2,Female,5,Prevalence,2.6956102676928408E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,False,2,Female,6,Incidence,5.287525431071027E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,2,Female,6,Incidence,6.4336109047287E-10,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,2,Female,6,Incidence,1.1437198592725303E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,2,Female,6,Incidence,1.972262467072088E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,1,True,2,Female,15,mortality,0.520645902963354,0.6149615350381351,0.6149615350381351
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,2,True,2,Female,15,mortality,0.5247620926931664,0.6092599982804747,0.6092599982804747
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,3,True,2,Female,15,mortality,0.5305052413964173,0.6042747965264408,0.6042747965264408
250,France,Gallbladder and biliary tract cancer,2019,5,1 to 4,4,True,2,Female,15,mortality,0.5374276670943883,0.5999872828016035,0.5999872828016035
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,False,1,Male,5,Prevalence,5.724445106823942E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,1,Male,5,Prevalence,9.345312563770089E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,1,Male,5,Prevalence,1.4821081545020452E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,1,Male,5,Prevalence,2.2847480547231366E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,1,Male,5,Prevalence,3.4260927977506354E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,False,1,Male,6,Incidence,3.8082270498381585E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,1,Male,6,Incidence,6.147053626723167E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,1,Male,6,Incidence,9.631668562450998E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,1,Male,6,Incidence,1.465995887509883E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,1,Male,6,Incidence,2.1691164440269215E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,True,1,Male,15,mortality,0.4375259167063252,0.48344130454560175,0.48344130454560175
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,1,Male,15,mortality,0.4412979926346324,0.4757375684431414,0.4757375684431414
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,1,Male,15,mortality,0.44470417258180056,0.4689764511128208,0.4689764511128208
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,1,Male,15,mortality,0.4475759502072367,0.46313266524207086,0.46313266524207086
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,1,Male,15,mortality,0.4498402567039809,0.45818092351832285,0.45818092351832285
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,False,2,Female,5,Prevalence,4.525989394984983E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,2,Female,5,Prevalence,7.3817826771189325E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,2,Female,5,Prevalence,1.1693265780812845E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,2,Female,5,Prevalence,1.7999439302930903E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,2,Female,5,Prevalence,2.6942019284389522E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,False,2,Female,6,Incidence,3.2995788176996703E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,2,Female,6,Incidence,5.3579591502315156E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,2,Female,6,Incidence,8.448557085163837E-09,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,2,Female,6,Incidence,1.2942388144789551E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,2,Female,6,Incidence,1.9272425348288416E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,5,True,2,Female,15,mortality,0.5450341613257876,0.5963788101315326,0.5963788101315326
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,6,True,2,Female,15,mortality,0.5528439475841508,0.5934307315417983,0.5934307315417983
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,7,True,2,Female,15,mortality,0.5604437437487917,0.5911244000579704,0.5911244000579704
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,8,True,2,Female,15,mortality,0.5675244705565394,0.5894411687056189,0.5894411687056189
250,France,Gallbladder and biliary tract cancer,2019,6,5 to 9,9,True,2,Female,15,mortality,0.5738981557194899,0.5883623905103138,0.5883623905103138
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,False,1,Male,5,Prevalence,5.0018190441285795E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,1,Male,5,Prevalence,7.115733662702815E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,1,Male,5,Prevalence,9.874216372819016E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,1,Male,5,Prevalence,1.3379700550667585E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,1,Male,5,Prevalence,1.7724342271412132E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,False,1,Male,6,Incidence,3.122656614033414E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,1,Male,6,Incidence,4.378186163116786E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,1,Male,6,Incidence,5.985522614792565E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,1,Male,6,Incidence,7.989725916761188E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,1,Male,6,Incidence,1.0429026762669198E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,True,1,Male,15,mortality,0.45151440780762786,0.45409593862900777,0.45409593862900777
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,1,Male,15,mortality,0.4526895726488809,0.45085242326155694,0.45085242326155694
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,1,Male,15,mortality,0.4535076257388715,0.44842509010340104,0.44842509010340104
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,1,Male,15,mortality,0.4541363872006763,0.4467886518419717,0.4467886518419717
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,1,Male,15,mortality,0.4547473707286011,0.4459178211646997,0.4459178211646997
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,False,2,Female,5,Prevalence,3.924439264439476E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,2,Female,5,Prevalence,5.5673825528388814E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,2,Female,5,Prevalence,7.698838810625591E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,2,Female,5,Prevalence,1.0387406551206473E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,2,Female,5,Prevalence,1.3688159292227644E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,False,2,Female,6,Incidence,2.7915158889280287E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,2,Female,6,Incidence,3.9361879811610966E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,2,Female,6,Incidence,5.4082351770625245E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,2,Female,6,Incidence,7.248597660437285E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,2,Female,6,Incidence,9.488748628142287E-08,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,10,True,2,Female,15,mortality,0.579495716797683,0.5878694184976251,0.5878694184976251
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,11,True,2,Female,15,mortality,0.584349606087209,0.5879436056931227,0.5879436056931227
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,12,True,2,Female,15,mortality,0.5885671744449824,0.5885663051223765,0.5885663051223765
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,13,True,2,Female,15,mortality,0.5923009266676691,0.5897188698109566,0.5897188698109566
250,France,Gallbladder and biliary tract cancer,2019,7,10 to 14,14,True,2,Female,15,mortality,0.5957208732498777,0.5913826527844329,0.5913826527844329
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,False,1,Male,5,Prevalence,2.2985341500985778E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,1,Male,5,Prevalence,2.9223420169749315E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,1,Male,5,Prevalence,3.648564873495198E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,1,Male,5,Prevalence,4.481314988684164E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,1,Male,5,Prevalence,5.425330166257741E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,False,1,Male,6,Incidence,1.3334416127926362E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,1,Male,6,Incidence,1.6731445076698627E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,1,Male,6,Incidence,2.064446057047089E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,1,Male,6,Incidence,2.5103086013742907E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,1,Male,6,Incidence,3.0150324917308655E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,True,1,Male,15,mortality,0.4554986814905339,0.44578731075901634,0.44578731075901634
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,1,Male,15,mortality,0.4565241095811115,0.44637183331235253,0.44637183331235253
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,1,Male,15,mortality,0.4579281238991803,0.44764610151213957,0.44764610151213957
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,1,Male,15,mortality,0.45978559473328057,0.44958482804580857,0.44958482804580857
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,1,Male,15,mortality,0.46214469820930065,0.4521627256007903,0.4521627256007903
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,False,2,Female,5,Prevalence,1.763756349567642E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,2,Female,5,Prevalence,2.225099438654311E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,2,Female,5,Prevalence,2.7524028928126604E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,2,Female,5,Prevalence,3.3438207130317215E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,2,Female,5,Prevalence,3.9971220998490624E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,False,2,Female,6,Incidence,1.214850996389033E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,2,Female,6,Incidence,1.523586024966907E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,2,Female,6,Incidence,1.8749279130563093E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,2,Female,6,Incidence,2.2682828552535996E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,2,Female,6,Incidence,2.703373085660135E-07,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,15,True,2,Female,15,mortality,0.5989924519792621,0.5935390070683755,0.5935390070683755
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,16,True,2,Female,15,mortality,0.602261569415287,0.5961692856883543,0.5961692856883543
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,17,True,2,Female,15,mortality,0.6056466593344103,0.599254841669939,0.599254841669939
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,18,True,2,Female,15,mortality,0.6092365384044971,0.6027770280386999,0.6027770280386999
250,France,Gallbladder and biliary tract cancer,2019,8,15 to 19,19,True,2,Female,15,mortality,0.6130923188835018,0.6067171978202069,0.6067171978202069
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,False,1,Male,5,Prevalence,6.487510562100259E-07,1.4046520084803823E-06,6.736998559708137E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,1,Male,5,Prevalence,7.678560969258141E-07,1.4046520084803823E-06,6.736998559708137E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,1,Male,5,Prevalence,9.014487756719426E-07,1.4046520084803823E-06,6.736998559708137E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,1,Male,5,Prevalence,1.0517707334300205E-06,1.4046520084803823E-06,6.736998559708137E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,1,Male,5,Prevalence,1.2217573795915131E-06,1.4046520084803823E-06,6.736998559708137E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,False,1,Male,6,Incidence,3.585131724932637E-07,4.981462594525252E-07,2.6789917894684677E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,1,Male,6,Incidence,4.230159594409478E-07,4.981462594525252E-07,2.6789917894684677E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,1,Male,6,Incidence,4.963372183310248E-07,4.981462594525252E-07,2.6789917894684677E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,1,Male,6,Incidence,5.802140356902903E-07,4.981462594525252E-07,2.6789917894684677E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,1,Male,6,Incidence,6.768055531563343E-07,4.981462594525252E-07,2.6789917894684677E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,True,1,Male,15,mortality,0.46503149241109837,0.4553545068645163,0.4553545068645163
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,1,Male,15,mortality,0.4684549510694307,0.4591348845244174,0.4591348845244174
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,1,Male,15,mortality,0.4724116405686148,0.46347857126792513,0.46347857126792513
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,1,Male,15,mortality,0.4768896098156415,0.4683602797824702,0.4683602797824702
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,1,Male,15,mortality,0.48187136135433234,0.4737547227554837,0.4737547227554837
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,False,2,Female,5,Prevalence,4.711064957909557E-07,1.1681794642885506E-06,4.899547028247009E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,2,Female,5,Prevalence,5.486959003924949E-07,1.1681794642885506E-06,4.899547028247009E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,2,Female,5,Prevalence,6.330202036456741E-07,1.1681794642885506E-06,4.899547028247009E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,2,Female,5,Prevalence,7.251560098613416E-07,1.1681794642885506E-06,4.899547028247009E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,2,Female,5,Prevalence,8.267992389841374E-07,1.1681794642885506E-06,4.899547028247009E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,False,2,Female,6,Incidence,3.181174215419345E-07,4.158735458561222E-07,2.0600039363962255E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,2,Female,6,Incidence,3.704923234914191E-07,4.158735458561222E-07,2.0600039363962255E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,2,Female,6,Incidence,4.281066252163341E-07,4.158735458561222E-07,2.0600039363962255E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,2,Female,6,Incidence,4.920015686088456E-07,4.158735458561222E-07,2.0600039363962255E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,2,Female,6,Incidence,5.636610847683896E-07,4.158735458561222E-07,2.0600039363962255E-07
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,20,True,2,Female,15,mortality,0.61725161858274,0.6110567040400299,0.6110567040400299
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,21,True,2,Female,15,mortality,0.6217336143004691,0.615776899723739,0.615776899723739
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,22,True,2,Female,15,mortality,0.6265439322890684,0.620859137896904,0.620859137896904
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,23,True,2,Female,15,mortality,0.6316788131616491,0.6262847715850948,0.6262847715850948
250,France,Gallbladder and biliary tract cancer,2019,9,20 to 24,24,True,2,Female,15,mortality,0.637128342895088,0.6320351538138816,0.6320351538138816
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,False,1,Male,5,Prevalence,1.4150210018483976E-06,1.845693882504769E-06,6.522210176530631E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,1,Male,5,Prevalence,1.6357605216105396E-06,1.845693882504769E-06,6.522210176530631E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,1,Male,5,Prevalence,1.8886002284164444E-06,1.845693882504769E-06,6.522210176530631E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,1,Male,5,Prevalence,2.178363247200211E-06,1.845693882504769E-06,6.522210176530631E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,1,Male,5,Prevalence,2.5097872974260547E-06,1.845693882504769E-06,6.522210176530631E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,False,1,Male,6,Incidence,7.886708961373122E-07,6.949029118187233E-07,2.710779063613858E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,1,Male,6,Incidence,9.187147332469659E-07,6.949029118187233E-07,2.710779063613858E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,1,Male,6,Incidence,1.0701013782096528E-06,6.949029118187233E-07,2.710779063613858E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,1,Male,6,Incidence,1.2461377333678302E-06,6.949029118187233E-07,2.710779063613858E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,1,Male,6,Incidence,1.450124908690839E-06,6.949029118187233E-07,2.710779063613858E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,True,1,Male,15,mortality,0.4873359639661115,0.47963661287439685,0.47963661287439685
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,1,Male,15,mortality,0.4932604622634154,0.4859806628266409,0.4859806628266409
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,1,Male,15,mortality,0.4996207636613581,0.49276158529964675,0.49276158529964675
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,1,Male,15,mortality,0.5063921663982619,0.4999540929808457,0.4999540929808457
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,1,Male,15,mortality,0.5135496575256772,0.5075328985576688,0.5075328985576688
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,False,2,Female,5,Prevalence,9.402889005154268E-07,1.5446443142805803E-06,4.289914095424362E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,2,Female,5,Prevalence,1.0685679482204355E-06,1.5446443142805803E-06,4.289914095424362E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,2,Female,5,Prevalence,1.2150863829918215E-06,1.5446443142805803E-06,4.289914095424362E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,2,Female,5,Prevalence,1.383659701131435E-06,1.5446443142805803E-06,4.289914095424362E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,2,Female,5,Prevalence,1.5783009849781358E-06,1.5446443142805803E-06,4.289914095424362E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,False,2,Female,6,Incidence,6.45021877266336E-07,6.259767768394106E-07,1.8941191469576574E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,2,Female,6,Incidence,7.384464640320805E-07,6.259767768394106E-07,1.8941191469576574E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,2,Female,6,Incidence,8.46663234915576E-07,6.259767768394106E-07,1.8941191469576574E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,2,Female,6,Incidence,9.72681647990645E-07,6.259767768394106E-07,1.8941191469576574E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,2,Female,6,Incidence,1.1196931352537169E-06,6.259767768394106E-07,1.8941191469576574E-07
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,25,True,2,Female,15,mortality,0.6428787756076381,0.6380916376088344,0.6380916376088344
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,26,True,2,Female,15,mortality,0.6489140961247021,0.6444355759955228,0.6444355759955228
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,27,True,2,Female,15,mortality,0.6552170094498858,0.6510483219995171,0.6510483219995171
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,28,True,2,Female,15,mortality,0.661769532779151,0.6579112286463873,0.6579112286463873
250,France,Gallbladder and biliary tract cancer,2019,10,25 to 29,29,True,2,Female,15,mortality,0.6685533309789412,0.6650056489617031,0.6650056489617031
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,False,1,Male,5,Prevalence,2.8871930038613417E-06,5.0114472485963335E-06,1.5304949022421738E-06
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,1,Male,5,Prevalence,3.314121581005332E-06,5.0114472485963335E-06,1.5304949022421738E-06
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,1,Male,5,Prevalence,3.7929709958799807E-06,5.0114472485963335E-06,1.5304949022421738E-06
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,1,Male,5,Prevalence,4.324676976999958E-06,5.0114472485963335E-06,1.5304949022421738E-06
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,1,Male,5,Prevalence,4.908503388442804E-06,5.0114472485963335E-06,1.5304949022421738E-06
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,False,1,Male,6,Incidence,1.685179965416072E-06,1.955323267802087E-06,6.561419483213591E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,1,Male,6,Incidence,1.9540346265711207E-06,1.955323267802087E-06,6.561419483213591E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,1,Male,6,Incidence,2.258827536342529E-06,1.955323267802087E-06,6.561419483213591E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,1,Male,6,Incidence,2.6009194930194096E-06,1.955323267802087E-06,6.561419483213591E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,1,Male,6,Incidence,2.9807738100632276E-06,1.955323267802087E-06,6.561419483213591E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,True,1,Male,15,mortality,0.521068072532965,0.5154727147175469,0.5154727147175469
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,1,Male,15,mortality,0.5289221765603055,0.5237482541479115,0.5237482541479115
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,1,Male,15,mortality,0.5370867036503965,0.5323342295361935,0.5323342295361935
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,1,Male,15,mortality,0.5455363747666021,0.5412053535698241,0.5412053535698241
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,1,Male,15,mortality,0.5542459056443269,0.5503363389362343,0.5503363389362343
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,False,2,Female,5,Prevalence,1.8030468987704436E-06,3.0050451554872528E-06,7.168551837674137E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,2,Female,5,Prevalence,2.0617968695328924E-06,3.0050451554872528E-06,7.168551837674137E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,2,Female,5,Prevalence,2.3581816468371733E-06,3.0050451554872528E-06,7.168551837674137E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,2,Female,5,Prevalence,2.6954733031781934E-06,3.0050451554872528E-06,7.168551837674137E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,2,Female,5,Prevalence,3.0765444798891887E-06,3.0050451554872528E-06,7.168551837674137E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,False,2,Female,6,Incidence,1.2909690190157042E-06,1.2544043871862549E-06,3.2480067165128617E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,2,Female,6,Incidence,1.4897660566318074E-06,1.2544043871862549E-06,3.2480067165128617E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,2,Female,6,Incidence,1.7192486668481882E-06,1.2544043871862549E-06,3.2480067165128617E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,2,Female,6,Incidence,1.9824350011934844E-06,1.2544043871862549E-06,3.2480067165128617E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,2,Female,6,Incidence,2.2821722086714857E-06,1.2544043871862549E-06,3.2480067165128617E-07
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,30,True,2,Female,15,mortality,0.6755498969041652,0.6723129359710347,0.6723129359710347
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,31,True,2,Female,15,mortality,0.6827406434024308,0.6798144426999521,0.6798144426999521
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,32,True,2,Female,15,mortality,0.6901069478899452,0.687491522174025,0.687491522174025
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,33,True,2,Female,15,mortality,0.6976301728567482,0.6953255274188235,0.6953255274188235
250,France,Gallbladder and biliary tract cancer,2019,11,30 to 34,34,True,2,Female,15,mortality,0.7052916748181758,0.7032978114599175,0.7032978114599175
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,False,1,Male,5,Prevalence,5.542018572571347E-06,9.535066189159074E-06,2.9525245821200044E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,1,Male,5,Prevalence,6.22133230296971E-06,9.535066189159074E-06,2.9525245821200044E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,1,Male,5,Prevalence,6.941645738985325E-06,9.535066189159074E-06,2.9525245821200044E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,1,Male,5,Prevalence,7.698122561140124E-06,9.535066189159074E-06,2.9525245821200044E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,1,Male,5,Prevalence,8.487028040858796E-06,9.535066189159074E-06,2.9525245821200044E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,False,1,Male,6,Incidence,3.397951935585253E-06,3.7523882962699136E-06,1.303523899486353E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,1,Male,6,Incidence,3.8512728323479844E-06,3.7523882962699136E-06,1.303523899486353E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,1,Male,6,Incidence,4.339169928218958E-06,3.7523882962699136E-06,1.303523899486353E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,1,Male,6,Incidence,4.860251125038043E-06,3.7523882962699136E-06,1.303523899486353E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,1,Male,6,Incidence,5.41402862022763E-06,3.7523882962699136E-06,1.303523899486353E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,True,1,Male,15,mortality,0.5631900100358528,0.5597018983228554,0.5597018983228554
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,1,Male,15,mortality,0.5723434009807663,0.5692767444171184,0.5692767444171184
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,1,Male,15,mortality,0.5816807912764727,0.5790355899064543,0.5790355899064543
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,1,Male,15,mortality,0.5911768936427436,0.5889531474782944,0.5889531474782944
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,1,Male,15,mortality,0.6008064207759373,0.5990041298200698,0.5990041298200698
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,False,2,Female,5,Prevalence,3.503880857245379E-06,6.530330649784174E-06,1.7751153106033102E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,2,Female,5,Prevalence,3.979647558493103E-06,6.530330649784174E-06,1.7751153106033102E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,2,Female,5,Prevalence,4.505807280846936E-06,6.530330649784174E-06,1.7751153106033102E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,2,Female,5,Prevalence,5.0842850398351374E-06,6.530330649784174E-06,1.7751153106033102E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,2,Female,5,Prevalence,5.717171249477839E-06,6.530330649784174E-06,1.7751153106033102E-06
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,False,2,Female,6,Incidence,2.621144652698182E-06,2.8502542841037143E-06,8.314139483402829E-07
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,2,Female,6,Incidence,3.001917383380579E-06,2.8502542841037143E-06,8.314139483402829E-07
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,2,Female,6,Incidence,3.4270155979395604E-06,2.8502542841037143E-06,8.314139483402829E-07
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,2,Female,6,Incidence,3.899038865320358E-06,2.8502542841037143E-06,8.314139483402829E-07
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,2,Female,6,Incidence,4.4208063805653495E-06,2.8502542841037143E-06,8.314139483402829E-07
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,35,True,2,Female,15,mortality,0.7130728080202813,0.7113897273228772,0.7113897273228772
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,36,True,2,Female,15,mortality,0.7209549258926454,0.7195826280332724,0.7195826280332724
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,37,True,2,Female,15,mortality,0.7289193815871163,0.7278578666166731,0.7278578666166731
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,38,True,2,Female,15,mortality,0.7369475281664292,0.7361967960986493,0.7361967960986493
250,France,Gallbladder and biliary tract cancer,2019,12,35 to 39,39,True,2,Female,15,mortality,0.7450207186664203,0.7445807695047708,0.7445807695047708
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,False,1,Male,5,Prevalence,9.307015369716177E-06,2.24871433611193E-05,6.984969509916727E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,1,Male,5,Prevalence,1.0160380751889831E-05,2.24871433611193E-05,6.984969509916727E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,1,Male,5,Prevalence,1.1054076800956043E-05,2.24871433611193E-05,6.984969509916727E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,1,Male,5,Prevalence,1.2000280152376272E-05,2.24871433611193E-05,6.984969509916727E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,1,Male,5,Prevalence,1.3016358803167013E-05,2.24871433611193E-05,6.984969509916727E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,False,1,Male,6,Incidence,6.001743038498785E-06,8.431231126428649E-06,2.792074036542587E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,1,Male,6,Incidence,6.627169929307224E-06,8.431231126428649E-06,2.792074036542587E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,1,Male,6,Incidence,7.297275763353489E-06,8.431231126428649E-06,2.792074036542587E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,1,Male,6,Incidence,8.022592800089214E-06,8.431231126428649E-06,2.792074036542587E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,1,Male,6,Incidence,8.817211043114039E-06,8.431231126428649E-06,2.792074036542587E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,True,1,Male,15,mortality,0.6105440853657895,0.6091632496192113,0.6091632496192113
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,1,Male,15,mortality,0.6203646001002848,0.6194052195631505,0.6194052195631505
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,1,Male,15,mortality,0.630242677666978,0.6297047523393182,0.6297047523393182
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,1,Male,15,mortality,0.6401530307533251,0.6400365606351458,0.6400365606351458
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,1,Male,15,mortality,0.6500703720467621,0.6503753571380639,0.6503753571380639
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,False,2,Female,5,Prevalence,6.406951404175267E-06,1.3184218517677585E-05,3.4738416871792883E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,2,Female,5,Prevalence,7.156747135354804E-06,1.3184218517677585E-05,3.4738416871792883E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,2,Female,5,Prevalence,7.97055039416145E-06,1.3184218517677585E-05,3.4738416871792883E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,2,Female,5,Prevalence,8.853430601209803E-06,1.3184218517677585E-05,3.4738416871792883E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,2,Female,5,Prevalence,9.811694424337875E-06,1.3184218517677585E-05,3.4738416871792883E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,False,2,Female,6,Incidence,4.995526476498182E-06,6.049905477867062E-06,1.7268960492785333E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,2,Female,6,Incidence,5.626980302640099E-06,6.049905477867062E-06,1.7268960492785333E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,2,Female,6,Incidence,6.319706421417207E-06,6.049905477867062E-06,1.7268960492785333E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,2,Female,6,Incidence,7.079170617301749E-06,6.049905477867062E-06,1.7268960492785333E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,2,Female,6,Incidence,7.911904018419501E-06,6.049905477867062E-06,1.7268960492785333E-06
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,40,True,2,Female,15,mortality,0.7531203061153112,0.7529911398606077,0.7529911398606077
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,41,True,2,Female,15,mortality,0.7612276435393097,0.76140926019173,0.76140926019173
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,42,True,2,Female,15,mortality,0.7693240839641281,0.7698164835237078,0.7698164835237078
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,43,True,2,Female,15,mortality,0.7773909804153649,0.7781941628821106,0.7781941628821106
250,France,Gallbladder and biliary tract cancer,2019,13,40 to 44,44,True,2,Female,15,mortality,0.7854096859185961,0.7865236512925089,0.7865236512925089
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,False,1,Male,5,Prevalence,1.4124172781333617E-05,2.112851330020851E-05,7.409917598026542E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,1,Male,5,Prevalence,1.5348754214941158E-05,2.112851330020851E-05,7.409917598026542E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,1,Male,5,Prevalence,1.671652871974861E-05,2.112851330020851E-05,7.409917598026542E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,1,Male,5,Prevalence,1.825333548671574E-05,2.112851330020851E-05,7.409917598026542E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,1,Male,5,Prevalence,1.998255681314201E-05,2.112851330020851E-05,7.409917598026542E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,False,1,Male,6,Incidence,9.698338910020739E-06,1.1469181566051924E-05,4.360339056610627E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,1,Male,6,Incidence,1.068545455399367E-05,1.1469181566051924E-05,4.360339056610627E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,1,Male,6,Incidence,1.1799144746061633E-05,1.1469181566051924E-05,4.360339056610627E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,1,Male,6,Incidence,1.3059793071680857E-05,1.1469181566051924E-05,4.360339056610627E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,1,Male,6,Incidence,1.4486319278173972E-05,1.1469181566051924E-05,4.360339056610627E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,True,1,Male,15,mortality,0.6599694142347209,0.6606958545355042,0.6606958545355042
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,1,Male,15,mortality,0.6698248700046326,0.6709727655148972,0.6709727655148972
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,1,Male,15,mortality,0.6796114520439285,0.6811808027636743,0.6811808027636743
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,1,Male,15,mortality,0.6893038730400396,0.6912946789692668,0.6912946789692668
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,1,Male,15,mortality,0.698876845680397,0.7012891068191057,0.7012891068191057
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,False,2,Female,5,Prevalence,1.0852979838929615E-05,2.086975605665943E-05,6.356555172331532E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,2,Female,5,Prevalence,1.198627043867196E-05,2.086975605665943E-05,6.356555172331532E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,2,Female,5,Prevalence,1.3221822374516408E-05,2.086975605665943E-05,6.356555172331532E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,2,Female,5,Prevalence,1.4571004207113261E-05,2.086975605665943E-05,6.356555172331532E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,2,Female,5,Prevalence,1.604605845542519E-05,2.086975605665943E-05,6.356555172331532E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,False,2,Female,6,Incidence,8.825593139568761E-06,1.098140089308471E-05,3.541680717825831E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,2,Female,6,Incidence,9.829107912637153E-06,1.098140089308471E-05,3.541680717825831E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,2,Female,6,Incidence,1.0932458138809643E-05,1.098140089308471E-05,3.541680717825831E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,2,Female,6,Incidence,1.214667473034159E-05,1.098140089308471E-05,3.541680717825831E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,2,Female,6,Incidence,1.3483618976531767E-05,1.098140089308471E-05,3.541680717825831E-06
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,45,True,2,Female,15,mortality,0.7933615534993922,0.7947863017804726,0.7947863017804726
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,46,True,2,Female,15,mortality,0.8012279361833238,0.8029634673715711,0.8029634673715711
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,47,True,2,Female,15,mortality,0.8089901869959606,0.8110365010913749,0.8110365010913749
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,48,True,2,Female,15,mortality,0.8166296589628724,0.8189867559654539,0.8189867559654539
250,France,Gallbladder and biliary tract cancer,2019,14,45 to 49,49,True,2,Female,15,mortality,0.8241277051096292,0.826795585019378,0.826795585019378
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,False,1,Male,5,Prevalence,2.1923664101083787E-05,3.220563023666945E-05,1.1927700323571588E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,1,Male,5,Prevalence,2.4091422069290752E-05,3.220563023666945E-05,1.1927700323571588E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,1,Male,5,Prevalence,2.6495874353445223E-05,3.220563023666945E-05,1.1927700323571588E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,1,Male,5,Prevalence,2.9143082854248692E-05,3.220563023666945E-05,1.1927700323571588E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,1,Male,5,Prevalence,3.203644126738555E-05,3.220563023666945E-05,1.1927700323571588E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,False,1,Male,6,Incidence,1.6095175465839406E-05,1.870337649218555E-05,7.140963514984752E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,1,Male,6,Incidence,1.789976708356808E-05,1.870337649218555E-05,7.140963514984752E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,1,Male,6,Incidence,1.9910390432800227E-05,1.870337649218555E-05,7.140963514984752E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,1,Male,6,Incidence,2.2134676115763154E-05,1.870337649218555E-05,7.140963514984752E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,1,Male,6,Incidence,2.4578420538244318E-05,1.870337649218555E-05,7.140963514984752E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,True,1,Male,15,mortality,0.7083050826524319,0.7111387990006219,0.7111387990006219
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,1,Male,15,mortality,0.7175632966435753,0.7208184682012466,0.7208184682012466
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,1,Male,15,mortality,0.7266262003412584,0.7303028271084112,0.7303028271084112
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,1,Male,15,mortality,0.7354685064329124,0.7395665884095467,0.7395665884095467
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,1,Male,15,mortality,0.7440649276059682,0.7485844647920838,0.7485844647920838
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,False,2,Female,5,Prevalence,1.765980163852917E-05,3.089482835825711E-05,1.0883844605236697E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,2,Female,5,Prevalence,1.9425286104318E-05,3.089482835825711E-05,1.0883844605236697E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,2,Female,5,Prevalence,2.135545114733867E-05,3.089482835825711E-05,1.0883844605236697E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,2,Female,5,Prevalence,2.346279251599837E-05,3.089482835825711E-05,1.0883844605236697E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,2,Female,5,Prevalence,2.575907859740565E-05,3.089482835825711E-05,1.0883844605236697E-05
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,False,2,Female,6,Incidence,1.4955730043900334E-05,1.9004397061160057E-05,6.840042602541027E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,2,Female,6,Incidence,1.657572713888108E-05,1.9004397061160057E-05,6.840042602541027E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,2,Female,6,Incidence,1.8356287502032054E-05,1.9004397061160057E-05,6.840042602541027E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,2,Female,6,Incidence,2.0309724257408514E-05,1.9004397061160057E-05,6.840042602541027E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,2,Female,6,Incidence,2.2447689100291816E-05,1.9004397061160057E-05,6.840042602541027E-06
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,50,True,2,Female,15,mortality,0.8314656784618011,0.8344443412787172,0.8344443412787172
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,51,True,2,Female,15,mortality,0.838624932044958,0.8419143777690412,0.8419143777690412
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,52,True,2,Female,15,mortality,0.8455868188846701,0.8491870475159204,0.8491870475159204
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,53,True,2,Female,15,mortality,0.852332692006507,0.8562437035449249,0.8562437035449249
250,France,Gallbladder and biliary tract cancer,2019,15,50 to 54,54,True,2,Female,15,mortality,0.8588439044360389,0.8630656988816237,0.8630656988816237
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,False,1,Male,5,Prevalence,3.5178265713561005E-05,6.657894344491616E-05,2.5181270511787532E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,1,Male,5,Prevalence,3.85713140040208E-05,6.657894344491616E-05,2.5181270511787532E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,1,Male,5,Prevalence,4.22199186508836E-05,6.657894344491616E-05,2.5181270511787532E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,1,Male,5,Prevalence,4.613053570167006E-05,6.657894344491616E-05,2.5181270511787532E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,1,Male,5,Prevalence,5.0311686896641387E-05,6.657894344491616E-05,2.5181270511787532E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,False,1,Male,6,Incidence,2.7246601031442405E-05,3.621517109070149E-05,1.440129919336676E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,1,Male,6,Incidence,3.014432915336055E-05,3.621517109070149E-05,1.440129919336676E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,1,Male,6,Incidence,3.3277517672486556E-05,3.621517109070149E-05,1.440129919336676E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,1,Male,6,Incidence,3.6653121089339256E-05,3.621517109070149E-05,1.440129919336676E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,1,Male,6,Incidence,4.027894041063643E-05,3.621517109070149E-05,1.440129919336676E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,True,1,Male,15,mortality,0.7523901765478572,0.7573311689434541,0.7573311689434541
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,1,Male,15,mortality,0.7604189659460102,0.7657814135510889,0.7657814135510889
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,1,Male,15,mortality,0.7681260084878584,0.7739099113024185,0.7739099113024185
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,1,Male,15,mortality,0.7754860168608327,0.7816913748848746,0.7816913748848746
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,1,Male,15,mortality,0.7824737037523648,0.789100516985888,0.789100516985888
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,False,2,Female,5,Prevalence,2.825513898692026E-05,5.472793283026935E-05,1.7049227088465107E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,2,Female,5,Prevalence,3.096074764008783E-05,5.472793283026935E-05,1.7049227088465107E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,2,Female,5,Prevalence,3.388461907354359E-05,5.472793283026935E-05,1.7049227088465107E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,2,Female,5,Prevalence,3.703453238348538E-05,5.472793283026935E-05,1.7049227088465107E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,2,Female,5,Prevalence,4.0417593815635426E-05,5.472793283026935E-05,1.7049227088465107E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,False,2,Female,6,Incidence,2.4780924221199975E-05,3.553555435723252E-05,1.1444788934911277E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,2,Female,6,Incidence,2.7319086267151795E-05,3.553555435723252E-05,1.1444788934911277E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,2,Female,6,Incidence,3.0070662980171977E-05,3.553555435723252E-05,1.1444788934911277E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,2,Female,6,Incidence,3.304300052219242E-05,3.553555435723252E-05,1.1444788934911277E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,2,Female,6,Incidence,3.62424559792735E-05,3.553555435723252E-05,1.1444788934911277E-05
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,55,True,2,Female,15,mortality,0.8651018091988357,0.8696343865515879,0.8696343865515879
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,56,True,2,Female,15,mortality,0.8710877593204676,0.8759311195803869,0.8759311195803869
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,57,True,2,Female,15,mortality,0.8767831078265043,0.8819372509935904,0.8819372509935904
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,58,True,2,Female,15,mortality,0.8821692077425157,0.8876341338167693,0.8876341338167693
250,France,Gallbladder and biliary tract cancer,2019,16,55 to 59,59,True,2,Female,15,mortality,0.887227412094072,0.8930031210754927,0.8930031210754927
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,False,1,Male,5,Prevalence,5.477346176743602E-05,8.913408302480923E-05,3.289798131154475E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,1,Male,5,Prevalence,5.952689497396608E-05,8.913408302480923E-05,3.289798131154475E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,1,Male,5,Prevalence,6.458359389112691E-05,8.913408302480923E-05,3.289798131154475E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,1,Male,5,Prevalence,6.995593459824441E-05,8.913408302480923E-05,3.289798131154475E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,1,Male,5,Prevalence,7.565797475893824E-05,8.913408302480923E-05,3.289798131154475E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,False,1,Male,6,Incidence,4.416312672611005E-05,5.4123278824307735E-05,2.0986618078246734E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,1,Male,6,Incidence,4.831363230563895E-05,5.4123278824307735E-05,2.0986618078246734E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,1,Male,6,Incidence,5.273790253268518E-05,5.4123278824307735E-05,2.0986618078246734E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,1,Male,6,Incidence,5.7443052725250874E-05,5.4123278824307735E-05,2.0986618078246734E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,1,Male,6,Incidence,6.243663168055305E-05,5.4123278824307735E-05,2.0986618078246734E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,True,1,Male,15,mortality,0.7890637818498858,0.7961120502928903,0.7961120502928903
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,1,Male,15,mortality,0.7952309638408291,0.802700687493312,0.802700687493312
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,1,Male,15,mortality,0.8009499624126372,0.8088411412745846,0.8088411412745846
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,1,Male,15,mortality,0.8061954902527922,0.8145081243241392,0.8145081243241392
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,1,Male,15,mortality,0.8109422600489499,0.8196763493294066,0.8196763493294066
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,False,2,Female,5,Prevalence,4.404064331628536E-05,8.484309007838112E-05,2.9143194325474032E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,2,Female,5,Prevalence,4.791080272795621E-05,8.484309007838112E-05,2.9143194325474032E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,2,Female,5,Prevalence,5.203615206781224E-05,8.484309007838112E-05,2.9143194325474032E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,2,Female,5,Prevalence,5.6426505269904134E-05,8.484309007838112E-05,2.9143194325474032E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,2,Female,5,Prevalence,6.109423835413983E-05,8.484309007838112E-05,2.9143194325474032E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,False,2,Female,6,Incidence,3.967468425337963E-05,5.729570816010056E-05,2.0626480850475684E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,2,Female,6,Incidence,4.334506040602063E-05,5.729570816010056E-05,2.0626480850475684E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,2,Female,6,Incidence,4.7259226622192274E-05,5.729570816010056E-05,2.0626480850475684E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,2,Female,6,Incidence,5.1423737022780654E-05,5.729570816010056E-05,2.0626480850475684E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,2,Female,6,Incidence,5.584675410007955E-05,5.729570816010056E-05,2.0626480850475684E-05
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,60,True,2,Female,15,mortality,0.8919390739067433,0.8980255657953308,0.8980255657953308
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,61,True,2,Female,15,mortality,0.8962855462061015,0.9026828210018539,0.9026828210018539
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,62,True,2,Female,15,mortality,0.9002481820177257,0.9069562397206313,0.9069562397206313
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,63,True,2,Female,15,mortality,0.9038083343672275,0.9108271749772335,0.9108271749772335
250,France,Gallbladder and biliary tract cancer,2019,17,60 to 64,64,True,2,Female,15,mortality,0.9069473562803593,0.9142769797972304,0.9142769797972304
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,False,1,Male,5,Prevalence,8.170698615161053E-05,0.00015056770829981975,5.882056022330736E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,1,Male,5,Prevalence,8.812524900767952E-05,0.00015056770829981975,5.882056022330736E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,1,Male,5,Prevalence,9.494154400081931E-05,0.00015056770829981975,5.882056022330736E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,1,Male,5,Prevalence,0.00010219168354603131,0.00015056770829981975,5.882056022330736E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,1,Male,5,Prevalence,0.00010991747257960487,0.00015056770829981975,5.882056022330736E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,False,1,Male,6,Incidence,6.772786736682502E-05,9.25737670621305E-05,3.820109088891142E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,1,Male,6,Incidence,7.332907022329891E-05,9.25737670621305E-05,3.820109088891142E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,1,Male,6,Incidence,7.925669535199146E-05,9.25737670621305E-05,3.820109088891142E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,1,Male,6,Incidence,8.553148800759475E-05,9.25737670621305E-05,3.820109088891142E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,1,Male,6,Incidence,9.217718639169163E-05,9.25737670621305E-05,3.820109088891142E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,True,1,Male,15,mortality,0.815164984489449,0.8243205289778186,0.8243205289778186
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,1,Male,15,mortality,0.8188383762651598,0.8284153759568054,0.8284153759568054
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,1,Male,15,mortality,0.8219371480757593,0.8319356029537985,0.8319356029537985
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,1,Male,15,mortality,0.8244360126497957,0.8348559226562293,0.8348559226562293
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,1,Male,15,mortality,0.8263096828052553,0.8371510477515287,0.8371510477515287
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,False,2,Female,5,Prevalence,6.605510240179098E-05,0.00012507086347580775,4.4012645703833234E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,2,Female,5,Prevalence,7.132893246385462E-05,0.00012507086347580775,4.4012645703833234E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,2,Female,5,Prevalence,7.694014286392289E-05,0.00012507086347580775,4.4012645703833234E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,2,Female,5,Prevalence,8.291788000397791E-05,0.00012507086347580775,4.4012645703833234E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,2,Female,5,Prevalence,8.929568620235327E-05,0.00012507086347580775,4.4012645703833234E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,False,2,Female,6,Incidence,6.053872886147771E-05,8.526347170751211E-05,3.2205675980888175E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,2,Female,6,Incidence,6.551297449507413E-05,8.526347170751211E-05,3.2205675980888175E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,2,Female,6,Incidence,7.078602206908176E-05,8.526347170751211E-05,3.2205675980888175E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,2,Female,6,Incidence,7.637762761550634E-05,8.526347170751211E-05,3.2205675980888175E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,2,Female,6,Incidence,8.231028397708885E-05,8.526347170751211E-05,3.2205675980888175E-05
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,65,True,2,Female,15,mortality,0.9096466007834283,0.9172870072061917,0.9172870072061917
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,66,True,2,Female,15,mortality,0.9118874209047991,0.9198386102296879,0.9198386102296879
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,67,True,2,Female,15,mortality,0.9136511696799922,0.9219131418932884,0.9219131418932884
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,68,True,2,Female,15,mortality,0.9149192001679868,0.9234919552225634,0.9234919552225634
250,France,Gallbladder and biliary tract cancer,2019,18,65 to 69,69,True,2,Female,15,mortality,0.9156728655004337,0.924556403243083,0.924556403243083
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,False,1,Male,5,Prevalence,0.00011816367593736888,0.00018933192773114166,7.179441443627537E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,1,Male,5,Prevalence,0.00012697285862252694,0.00018933192773114166,7.179441443627537E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,1,Male,5,Prevalence,0.0001363783002439246,0.00018933192773114166,7.179441443627537E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,1,Male,5,Prevalence,0.00014639550520940492,0.00018933192773114166,7.179441443627537E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,1,Male,5,Prevalence,0.00015701308622282338,0.00018933192773114166,7.179441443627537E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,False,1,Male,6,Incidence,9.921743081229415E-05,0.00012940284211478503,5.3078220364652506E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,1,Male,6,Incidence,0.00010667079868081852,0.00012940284211478503,5.3078220364652506E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,1,Male,6,Incidence,0.00011454420068438981,0.00012940284211478503,5.3078220364652506E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,1,Male,6,Incidence,0.00012282517893400072,0.00012940284211478503,5.3078220364652506E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,1,Male,6,Incidence,0.00013147389470402198,0.00012940284211478503,5.3078220364652506E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,True,1,Male,15,mortality,0.8275328716226055,0.8387956909271281,0.8387956909271281
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,1,Male,15,mortality,0.8280802929136764,0.8397645648704581,0.8397645648704581
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,1,Male,15,mortality,0.8279266624288001,0.8400323822689497,0.8400323822689497
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,1,Male,15,mortality,0.8270467008142292,0.8395738558100345,0.8395738558100345
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,1,Male,15,mortality,0.825415140516237,0.8383636981811438,0.8383636981811438
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,False,2,Female,5,Prevalence,9.611051351420288E-05,0.0001742069211168257,6.120411697589034E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,2,Female,5,Prevalence,0.00010340091848351225,0.0001742069211168257,6.120411697589034E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,2,Female,5,Prevalence,0.00011120427481562653,0.0001742069211168257,6.120411697589034E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,2,Female,5,Prevalence,0.00011955287291690222,0.0001742069211168257,6.120411697589034E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,2,Female,5,Prevalence,0.00012846884793427948,0.0001742069211168257,6.120411697589034E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,False,2,Female,6,Incidence,8.8608079900528E-05,0.00012163049615947163,4.6059832565651025E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,2,Female,6,Incidence,9.529474723594325E-05,0.00012163049615947163,4.6059832565651025E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,2,Female,6,Incidence,0.00010239075263488488,0.00012163049615947163,4.6059832565651025E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,2,Female,6,Incidence,0.00010990933470003771,0.00012163049615947163,4.6059832565651025E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,2,Female,6,Incidence,0.00011785147523092793,0.00012163049615947163,4.6059832565651025E-05
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,70,True,2,Female,15,mortality,0.9158935190222577,0.9250878389804169,0.9250878389804169
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,71,True,2,Female,15,mortality,0.9155625146726346,0.9250676154601354,0.9250676154601354
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,72,True,2,Female,15,mortality,0.9146612079658135,0.924477085707808,0.924477085707808
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,73,True,2,Female,15,mortality,0.9131709583940522,0.9232976027490056,0.9232976027490056
250,France,Gallbladder and biliary tract cancer,2019,19,70 to 74,74,True,2,Female,15,mortality,0.9110731350372273,0.9215105196092963,0.9215105196092963
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,False,1,Male,5,Prevalence,0.0001681839606528536,0.00027231756142354844,0.00011148839172136249
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,1,Male,5,Prevalence,0.00017981785930189405,0.00027231756142354844,0.00011148839172136249
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,1,Male,5,Prevalence,0.00019177611299493768,0.00027231756142354844,0.00011148839172136249
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,1,Male,5,Prevalence,0.00020386956933794164,0.00027231756142354844,0.00011148839172136249
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,1,Male,5,Prevalence,0.00021586031365890634,0.00027231756142354844,0.00011148839172136249
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,False,1,Male,6,Incidence,0.00014041574995147545,0.00018867504268529602,8.246170052210642E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,1,Male,6,Incidence,0.00014953564054622453,0.00018867504268529602,8.246170052210642E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,1,Male,6,Incidence,0.00015867479268621382,0.00018867504268529602,8.246170052210642E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,1,Male,6,Incidence,0.00016763099795246813,0.00018867504268529602,8.246170052210642E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,1,Male,6,Incidence,0.00017616284850490758,0.00018867504268529602,8.246170052210642E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,True,1,Male,15,mortality,0.8230067411566315,0.8363766220697078,0.8363766220697078
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,1,Male,15,mortality,0.8197963222277038,0.8335873401631586,0.8335873401631586
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,1,Male,15,mortality,0.8157588295239987,0.8299705651489273,0.8299705651489273
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,1,Male,15,mortality,0.810869464187984,0.825501009714444,0.825501009714444
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,1,Male,15,mortality,0.8051039224387956,0.82015338654714,0.82015338654714
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,False,2,Female,5,Prevalence,0.00013795800502978484,0.00023835211914375543,9.077197715492997E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,2,Female,5,Prevalence,0.00014800279839240817,0.00023835211914375543,9.077197715492997E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,2,Female,5,Prevalence,0.00015855496065233696,0.00023835211914375543,9.077197715492997E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,2,Female,5,Prevalence,0.00016952854379273592,0.00023835211914375543,9.077197715492997E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,2,Female,5,Prevalence,0.000180794372624683,0.00023835211914375543,9.077197715492997E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,False,2,Female,6,Incidence,0.00012619993598774162,0.00017660334768633318,7.341959344712824E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,2,Female,6,Incidence,0.0001349126934994605,0.00017660334768633318,7.341959344712824E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,2,Female,6,Incidence,0.00014391635128572957,0.00017660334768633318,7.341959344712824E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,2,Female,6,Incidence,0.00015310036809289764,0.00017660334768633318,7.341959344712824E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,2,Female,6,Incidence,0.0001623131584771952,0.00017660334768633318,7.341959344712824E-05
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,75,True,2,Female,15,mortality,0.9083491290553778,0.9190971893142525,0.9190971893142525
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,76,True,2,Female,15,mortality,0.9049803802529189,0.9160389648894423,0.9160389648894423
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,77,True,2,Female,15,mortality,0.9009484310528815,0.9123171993604366,0.9123171993604366
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,78,True,2,Female,15,mortality,0.8962350313418931,0.907913245752805,0.907913245752805
250,France,Gallbladder and biliary tract cancer,2019,20,75 to 79,79,True,2,Female,15,mortality,0.8908223332378089,0.9028084570921173,0.9028084570921173
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,False,1,Male,5,Prevalence,0.00022746763213042612,0.00042365452138827417,0.00016315350228785186
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,1,Male,5,Prevalence,0.0002383783635327254,0.00042365452138827417,0.00016315350228785186
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,1,Male,5,Prevalence,0.000248261441150561,0.00042365452138827417,0.00016315350228785186
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,1,Male,5,Prevalence,0.0002567860375811627,0.00042365452138827417,0.00016315350228785186
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,1,Male,5,Prevalence,0.0002636423165938316,0.00042365452138827417,0.00016315350228785186
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,False,1,Male,6,Incidence,0.00018399829084789803,0.0002854503116395827,0.00011940707023250147
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,1,Male,6,Incidence,0.00019084747111138472,0.0002854503116395827,0.00011940707023250147
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,1,Male,6,Incidence,0.0001964194459433235,0.0002854503116395827,0.00011940707023250147
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,1,Male,6,Incidence,0.00020044189816108252,0.0002854503116395827,0.00011940707023250147
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,1,Male,6,Incidence,0.00020268255541386156,0.0002854503116395827,0.00011940707023250147
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,True,1,Male,15,mortality,0.7984388215053997,0.813902408334447,0.813902408334447
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,1,Male,15,mortality,0.7908524232739444,0.8067227877637975,0.8067227877637975
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,1,Male,15,mortality,0.7823258093379603,0.7985892375226191,0.7985892375226191
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,1,Male,15,mortality,0.7728447029340176,0.7894764702983461,0.7894764702983461
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,1,Male,15,mortality,0.7624021624969485,0.779359198778407,0.779359198778407
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,False,2,Female,5,Prevalence,0.0001921770640361979,0.0003522455214202887,0.00012639688458443345
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,2,Female,5,Prevalence,0.00020345576444391738,0.0003522455214202887,0.00012639688458443345
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,2,Female,5,Prevalence,0.0002143695548570032,0.0003522455214202887,0.00012639688458443345
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,2,Female,5,Prevalence,0.00022462805175016984,0.0003522455214202887,0.00012639688458443345
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,2,Female,5,Prevalence,0.00023392712189111955,0.0003522455214202887,0.00012639688458443345
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,False,2,Female,6,Incidence,0.00017136123133041736,0.0002609496771461324,0.0001056226167826609
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,2,Female,6,Incidence,0.0001800124672299971,0.0002609496771461324,0.0001056226167826609
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,2,Female,6,Incidence,0.00018800435149003768,0.0002609496771461324,0.0001056226167826609
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,2,Female,6,Incidence,0.00019505746900859257,0.0002609496771461324,0.0001056226167826609
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,2,Female,6,Incidence,0.00020089387046352003,0.0002609496771461324,0.0001056226167826609
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,80,True,2,Female,15,mortality,0.8846932371320667,0.8969841864039438,0.8969841864039438
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,81,True,2,Female,15,mortality,0.877831979590758,0.8904217867138549,0.8904217867138549
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,82,True,2,Female,15,mortality,0.8702250879537266,0.8831026110474189,0.8831026110474189
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,83,True,2,Female,15,mortality,0.8618628604041588,0.875008012430208,0.875008012430208
250,France,Gallbladder and biliary tract cancer,2019,30,80 to 84,84,True,2,Female,15,mortality,0.8527415540107169,0.8661193438877908,0.8661193438877908
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,False,1,Male,5,Prevalence,0.000268563408171673,0.0005106659633129332,0.00021383602971887674
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,1,Male,5,Prevalence,0.0002713469096366375,0.0005106659633129332,0.00021383602971887674
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,1,Male,5,Prevalence,0.00027187403644772664,0.0005106659633129332,0.00021383602971887674
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,1,Male,5,Prevalence,0.00027012455268631425,0.0005106659633129332,0.00021383602971887674
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,1,Male,5,Prevalence,0.0002661858348194667,0.0005106659633129332,0.00021383602971887674
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,False,1,Male,6,Incidence,0.00020297060787687304,0.0004012153240081466,0.00018743792730630782
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,1,Male,6,Incidence,0.0002012161146334727,0.0004012153240081466,0.00018743792730630782
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,1,Male,6,Incidence,0.00019742524306392824,0.0004012153240081466,0.00018743792730630782
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,1,Male,6,Incidence,0.0001917092674387634,0.0004012153240081466,0.00018743792730630782
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,1,Male,6,Incidence,0.0001842856190022164,0.0004012153240081466,0.00018743792730630782
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,True,1,Male,15,mortality,0.7510023702409048,0.7682121356502356,0.7682121356502356
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,1,Male,15,mortality,0.7386656850741714,0.7560099936012619,0.7560099936012619
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,1,Male,15,mortality,0.7254350004827597,0.7427274853189152,0.7427274853189152
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,1,Male,15,mortality,0.7113832308330744,0.728339323490629,0.728339323490629
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,1,Male,15,mortality,0.6966214471336291,0.7128202208038332,0.7128202208038332
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,False,2,Female,5,Prevalence,0.00024196890670057843,0.0005060867841957492,0.00017575146508731198
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,2,Female,5,Prevalence,0.0002484846293486474,0.0005060867841957492,0.00017575146508731198
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,2,Female,5,Prevalence,0.00025325806364505935,0.0005060867841957492,0.00017575146508731198
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,2,Female,5,Prevalence,0.0002561471947209896,0.0005060867841957492,0.00017575146508731198
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,2,Female,5,Prevalence,0.000257101577874405,0.0005060867841957492,0.00017575146508731198
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,False,2,Female,6,Incidence,0.00020525912610652614,0.00042252751284009885,0.00016395532781788666
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,2,Female,6,Incidence,0.00020794611800747166,0.00042252751284009885,0.00016395532781788666
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,2,Female,6,Incidence,0.00020881802351887068,0.00042252751284009885,0.00016395532781788666
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,2,Female,6,Incidence,0.0002078276419883786,0.00042252751284009885,0.00016395532781788666
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,2,Female,6,Incidence,0.00020503031132647662,0.00042252751284009885,0.00016395532781788666
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,85,True,2,Female,15,mortality,0.8428664621121914,0.8564179584457374,0.8564179584457374
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,86,True,2,Female,15,mortality,0.8322560183890535,0.8458852091296181,0.8458852091296181
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,87,True,2,Female,15,mortality,0.8209469603331573,0.8345024489650021,0.8345024489650021
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,88,True,2,Female,15,mortality,0.8090004082689884,0.8222510309774611,0.8222510309774611
250,France,Gallbladder and biliary tract cancer,2019,31,85 to 89,89,True,2,Female,15,mortality,0.7965084702809895,0.8091123081925629,0.8091123081925629
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,False,1,Male,5,Prevalence,0.00026025486335726314,0.000396518335149722,0.00016535143735078988
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,1,Male,5,Prevalence,0.000252632558987703,0.000396518335149722,0.00016535143735078988
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,1,Male,5,Prevalence,0.00024371061058509383,0.000396518335149722,0.00016535143735078988
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,1,Male,5,Prevalence,0.0002339516833748223,0.000396518335149722,0.00016535143735078988
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,1,Male,5,Prevalence,0.00022386453725888871,0.000396518335149722,0.00016535143735078988
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,False,1,Male,6,Incidence,0.00017546996211214566,0.0004161453434409247,0.00019020327161233663
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,1,Male,6,Incidence,0.00016565925400198895,0.0004161453434409247,0.00019020327161233663
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,1,Male,6,Incidence,0.0001553069415443384,0.0004161453434409247,0.00019020327161233663
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,1,Male,6,Incidence,0.00014489268104367228,0.0004161453434409247,0.00019020327161233663
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,1,Male,6,Incidence,0.0001348899831618169,0.0004161453434409247,0.00019020327161233663
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,True,1,Male,15,mortality,0.6813068249067319,0.6961448899459608,0.6961448899459608
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,1,Male,15,mortality,0.66564921212336,0.6782880436044412,0.6782880436044412
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,1,Male,15,mortality,0.6499148605974762,0.6592243944667051,0.6592243944667051
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,1,Male,15,mortality,0.6344257888443131,0.6389286552201843,0.6389286552201843
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,1,Male,15,mortality,0.6195534456014019,0.6173755385523099,0.6173755385523099
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,False,2,Female,5,Prevalence,0.0002561732295351428,0.00045841464588240727,0.00016297209059752197
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,2,Female,5,Prevalence,0.00025351952741232953,0.00045841464588240727,0.00016297209059752197
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,2,Female,5,Prevalence,0.00024939746373815486,0.00045841464588240727,0.00016297209059752197
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,2,Female,5,Prevalence,0.00024414955453893353,0.00045841464588240727,0.00016297209059752197
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,2,Female,5,Prevalence,0.00023818261184720536,0.00045841464588240727,0.00016297209059752197
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,False,2,Female,6,Incidence,0.00020058819757689644,0.0004896381220959064,0.0001891464191117502
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,2,Female,6,Incidence,0.00019476469805637181,0.0004896381220959064,0.0001891464191117502
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,2,Female,6,Incidence,0.0001879089751840739,0.0004896381220959064,0.0001891464191117502
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,2,Female,6,Incidence,0.00018043204717286827,0.0004896381220959064,0.0001891464191117502
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,2,Female,6,Incidence,0.00017277714670300702,0.0004896381220959064,0.0001891464191117502
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,90,True,2,Female,15,mortality,0.7836006921454016,0.7950676336358802,0.7950676336358802
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,91,True,2,Female,15,mortality,0.7704493831601119,0.7800983603329801,0.7800983603329801
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,92,True,2,Female,15,mortality,0.7572726338804564,0.7641858413094331,0.7641858413094331
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,93,True,2,Female,15,mortality,0.7443337806837033,0.7473114295908103,0.7473114295908103
250,France,Gallbladder and biliary tract cancer,2019,32,90 to 94,94,True,2,Female,15,mortality,0.7319362358403824,0.7294564782026813,0.7294564782026813
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,False,1,Male,5,Prevalence,0.00021397602955039173,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,1,Male,5,Prevalence,0.00020480215823675486,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,1,Male,5,Prevalence,0.0001968202076027537,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,1,Male,5,Prevalence,0.00019044373145765298,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,1,Male,5,Prevalence,0.00018600164283272993,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,1,Male,5,Prevalence,0.00018372218955409574,0.00021477533268017405,8.733202915168138E-05
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,False,1,Male,6,Incidence,0.00012573570375463866,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,1,Male,6,Incidence,0.00011780510085591649,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,1,Male,6,Incidence,0.00011139519249580562,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,1,Male,6,Incidence,0.00010671753446845935,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,1,Male,6,Incidence,0.00010389965965182213,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,1,Male,6,Incidence,0.00010299276875927728,0.0004138904540594599,0.0001675781270544926
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,1,Male,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,True,1,Male,15,mortality,0.6057058672995058,0.5945397571505127,0.5945397571505127
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,1,Male,15,mortality,0.5933083484564499,0.5703960237022243,0.5703960237022243
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,1,Male,15,mortality,0.5827786688458173,0.5449190508948751,0.5449190508948751
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,1,Male,15,mortality,0.5744989695087037,0.5180835514158977,0.5180835514158977
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,1,Male,15,mortality,0.5687872234426911,0.4898642379527214,0.4898642379527214
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,1,Male,15,mortality,0.5658716966730006,0.46023582319277967,0.46023582319277967
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,False,2,Female,5,Prevalence,0.0002319412998441544,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,2,Female,5,Prevalence,0.0002258788241849106,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,2,Female,5,Prevalence,0.00022042720881843158,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,2,Female,5,Prevalence,0.0002159694244404153,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,2,Female,5,Prevalence,0.0002128152312612962,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,2,Female,5,Prevalence,0.00021118210103571658,0.00025705558323328123,0.00010622185734624417
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,False,2,Female,6,Incidence,0.00016538793714153364,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,2,Female,6,Incidence,0.0001586784128408178,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,2,Female,6,Incidence,0.000153007802230747,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,2,Female,6,Incidence,0.00014866262941760328,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,2,Female,6,Incidence,0.0001458465574720611,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,2,Female,6,Incidence,0.0001446771452839381,0.0004958062029719361,0.00020578827879936303
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,2,Female,7,remission,0,0,0
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,95,True,2,Female,15,mortality,0.7204130279830143,0.7106023401706163,0.7106023401706163
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,96,True,2,Female,15,mortality,0.7101110691946529,0.690730368520184,0.690730368520184
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,97,True,2,Female,15,mortality,0.701370998128962,0.6698219162769559,0.6698219162769559
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,98,True,2,Female,15,mortality,0.694504300661274,0.6478583364665016,0.6478583364665016
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,99,True,2,Female,15,mortality,0.6897701035231775,0.62482098211439,0.62482098211439
250,France,Gallbladder and biliary tract cancer,2019,235,95 to 100,100,True,2,Female,15,mortality,0.6873544019496557,0.6006912062461924,0.6006912062461924
